Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Zosano Pharma Corporation ZSANQ

Healthcare Biotechnology
Zosano Pharma Corp is registered with the U.S. Security and Exchange Commission and incorporated in the state of Delaware. Zosano Pharma Corp is primarely in the business of pharmaceutical preparations. For financial reporting, their fiscal year ends on December 31st. This page includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K... see more

Recent & Breaking News (EXPM:ZSANQ)

Lifshitz & Miller Law Firm Announces Investigation of Ashford Hospitality Prime, Inc., Cobalt International Energy, Inc., Inovalon Holdings, Inc., Ooma, Inc., OvaScience, Inc., Swift Transportation Company, and Zosano Pharma Corporation

PR Newswire February 25, 2016

INVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Violations of Federal Securities Laws by the Board of Zosano Pharma Corporation -- ZSAN

PR Newswire February 9, 2016

SHAREHOLDER NOTICE: Khang & Khang LLP Announces an Ongoing Investigation of Claims against Zosano Pharma Corporation and Encourages Investors With Losses to Contact the Firm

Business Wire February 9, 2016

ZOSANO PHARMA SHAREHOLDER ALERT: Shareholder Rights Law Firm Johnson & Weaver, LLP Continues its Investigation of Zosano Pharma Corporation; Encourages Investors to Contact the Firm for Information Concerning Their Legal Rights

Business Wire February 9, 2016

IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces an Ongoing Investigation of Claims against Zosano Pharma Corporation and Encourages Investors With Losses to Contact the Firm

Business Wire January 21, 2016

Harwood Feffer LLP Announces Investigation of Zosano Pharma Corporation

PR Newswire January 21, 2016

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Violations of Federal Securities Laws by the Board of Zosano Pharma Corporation

Business Wire January 21, 2016

Robbins Arroyo LLP Is Investigating the Officers and Directors of Zosano Pharma Corporation (ZSAN) on Behalf of Shareholders

Business Wire January 20, 2016

Zosano Pharma Announces Appointment of Konstantinos Alataris, Ph.D. as President and Chief Executive Officer

GlobeNewswire January 7, 2016

ZOSANO PHARMA SHAREHOLDER ALERT: Shareholder Rights Law Firm Johnson & Weaver, LLP Announces Investigation of Zosano Pharma Corporation; Encourages Investors to Contact the Firm for Information Concerning Their Legal Rights

Business Wire January 6, 2016

Zosano Pharma to Present at the Stifel 2015 Healthcare Conference

GlobeNewswire November 10, 2015

Zosano Pharma Reports Third Quarter 2015 Financial Results

GlobeNewswire November 9, 2015

Zosano Pharma to Announce Third Quarter 2015 Financial Results, Host Conference Call and Live Webcast on November 9, 2015

GlobeNewswire November 3, 2015

Zosano Pharma Announces Positive Phase 1 Results for Its ZP-Triptan Patch Program for Treatment of Migraine

GlobeNewswire November 2, 2015

Zosano Pharma Announces Positive Phase 2 Results for Its ZP-Glucagon Patch Program for Treatment of Severe Hypoglycemia

GlobeNewswire October 13, 2015

Zosano Pharma Resumes Development of Weekly ZP-PTH Treatment for Severe Osteoporosis

GlobeNewswire September 28, 2015

Zosano Pharma to Present at the Ladenburg Thalmann 2015 Healthcare Conference

GlobeNewswire September 23, 2015

Zosano Pharma Announces New Executive Appointment and Management Change

GlobeNewswire September 8, 2015

Zosano Pharma Completes Enrollment in Phase 1 Study for Microneedle Patch Delivery of Zolmitriptan for the Treatment of Migraine

GlobeNewswire September 1, 2015

Zosano Pharma Reports Second Quarter 2015 Financial Results

GlobeNewswire August 12, 2015